Published • loading... • Updated
IAVI Awarded $36 Million From BARDA for Bundibugyo Virus Vaccine Development
The award will fund manufacturing and an early-stage trial as IAVI and partners work to speed doses for outbreak response.
Summary by Hastings Tribune
6 Articles
6 Articles
Hastings Tribune+2 Reposted by 2 other sources
IAVI Awarded $36 Million From BARDA for Bundibugyo Virus Vaccine Development
Initial award funds process development, manufacturing, and clinical evaluation of a single-dose vaccine candidate through strategic partnerships with Hilleman Laboratories, SK bioscience, and IDT Biologika
·Nebraska, United States
Read Full Article
IAVI Awarded $36 Million From BARDA for Bundibugyo Virus Vaccine Development - Swaziland Online News
Initial award funds process development, manufacturing, and clinical evaluation of a single-dose vaccine candidate through strategic partnerships with Hilleman Laboratories, SK bioscience, and IDT Biologika NEW YORK, NY, SINGAPORE, SG INCHEON, SOUTH KO...
Coverage Details
Total News Sources6
Leaning Left0Leaning Right0Center4Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
